Literature DB >> 90132

Neuromyopathy during chronic amiodarone treatment. A case report.

C Meier, B Kauer, U Müller, H P Ludin.   

Abstract

Clinical, electrophysiological, and the nerve and muscle biopsy findings from a case treated with amiodarone are reported. Marked distal motor and sensory impairment and distal muscular atrophy were observed clinically. The electrophysiological examination revealed normal motor and sensory conduction velocities in the median nerve; the sensory action potentials were polyphasic and reduced in amplitude. Electromyography revealed denervation potentials and severe loss of motor units in the M. extensor digitorum brevis and in the M. tibialis anterior. The light and electronmicroscopical study of a N. suralis biopsy displayed total loss of large myelinated fibers and an almost total reduction of small myelinated fibers. The number of unmyelinated axons was markedly reduced. Fibrocytes and degenerative axons polymorphous inclusion bodies were present in Schwann cells. The muscle biopsy revealed both neurogenic and myopathic changes. Lipid storage was also present in the muscle fibers. Physical and chemical analysis of the nerve and muscle biopsy revealed the content of iodine to be more than 40 times increased. The findings indicate damage of axons, schwann cells and muscle fibers. It is suggested that the lipid storage in nerve and muscle tissue might be related to the accumulation of the drug or its metabolites.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90132     DOI: 10.1007/BF00314147

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Amiodarone neuropathy (author's transl).

Authors:  H E Kaeser; J Ulrich; R Wüthrich
Journal:  Schweiz Rundsch Med Prax       Date:  1976-09-14

2.  [Electron microscopic study of nerve, muscle and skin lesions induced by perhexiline maleate (author's transl)].

Authors:  J M Mussini; J J Hauw; R Escourolle
Journal:  Acta Neuropathol       Date:  1977-04-29       Impact factor: 17.088

3.  [2 cases of peripheral neuropathy caused by amiodarone].

Authors:  C Fischer; B Bady; M Trillet; B Schott
Journal:  Nouv Presse Med       Date:  1977-11-19

4.  Light-microscopic demonstration of drug-induced myelin bodies in the liver of rats.

Authors:  G R Staiger
Journal:  Experientia       Date:  1974-04-15

5.  Letter: Amiodarone and neurological side-effects.

Authors:  F Lustman; G Monseu
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

6.  [Amiodarone neuropathy].

Authors:  H E Kaeser
Journal:  Schweiz Med Wochenschr       Date:  1974-04-27

7.  [Letter: Hyperthyroidism and benzodiarone: regressive pyramidal syndrome of the lower limbs].

Authors:  N Herne; A Chagnon; J Marion; F Le Gall
Journal:  Nouv Presse Med       Date:  1973-10-13

8.  The normal sural nerve in man. II. Changes in the axons and Schwann cells due to ageing.

Authors:  J Ochoa; W G Mair
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

9.  Amiodarone-induced lipidosis-like alterations in ocular tissues of rats.

Authors:  H Bockhardt; D Drenckhahn; R Lüllmann-Rauch
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-07-17

10.  Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors:  M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

  10 in total
  18 in total

1.  Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.

Authors:  N A Shaikh; E Downar; J Butany
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

2.  Adverse reactions during treatment with amiodarone hydrochloride.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-27

3.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors:  M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Familial disorder of the central and peripheral nervous systems with particular cytoplasmic lamellated inclusions in peripheral nerves, muscle satellite cells, and blood capillaries.

Authors:  F M Tomé; P Brunet; M Fardeau; F Hentati; J Reix
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

Review 5.  Adverse effects of amiodarone. Pathogenesis, incidence and management.

Authors:  G V Naccarelli; R L Rinkenberger; A H Dougherty; D M Fitzgerald
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

6.  Peripheral neuropathy during longterm high-dose amiodarone therapy.

Authors:  A G Fraser; I N McQueen; A H Watt; M R Stephens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-06       Impact factor: 10.154

Review 7.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

9.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

10.  Myopathy during amiodarone treatment: a case report.

Authors:  F Carella; E Riva; L Morandi; E Cappiello; A Mangoni
Journal:  Ital J Neurol Sci       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.